Cargando…

Questionable utility of digoxin in left-ventricular assist device recipients: A multicenter, retrospective analysis

BACKGROUND: While clinical experience with left ventricular assist devices (LVAD) continues to grow and evolve, little is known regarding the ongoing use of certain medications in this population. We sought to evaluate the utility of digoxin in LVAD recipients and its association with outcomes. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Mustafa M., Roukoz, Henri, Trivedi, Jaimin R., Bhan, Adarsh, Ravichandran, Ashwin, Dhawan, Rahul, Cowger, Jennifer, Bhat, Geetha, Birks, Emma J., Slaughter, Mark S., Gopinathannair, Rakesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876793/ https://www.ncbi.nlm.nih.gov/pubmed/31765397 http://dx.doi.org/10.1371/journal.pone.0225628

Ejemplares similares

Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients
por: Gopinathannair, Rakesh, et al.
Publicado: (2018)

Continued versus Suspended Cardiac Resynchronization Therapy after Left Ventricular Assist Device Implantation
por: Roukoz, Henri, et al.
Publicado: (2020)

Implantable cardioverter-defibrillator–related procedures and associated complications in continuous flow left ventricular assist device recipients: A multicenter experience
por: Ravichandran, Ashwin, et al.
Publicado: (2021)

Amiodarone Use and All‐Cause Mortality in Patients With a Continuous‐Flow Left Ventricular Assist Device
por: Gopinathannair, Rakesh, et al.
Publicado: (2022)

Inappropriate use of digoxin in patients presenting with digoxin toxicity
por: Tatlisu, Mustafa Adem, et al.
Publicado: (2015)

Atrial tachycardia involving both recipient and donor right atria through two atrioatrial connections in a heart transplant recipient
por: Von Wald, Lisa, et al.
Publicado: (2020)

Use of digoxin-specific antibody fragments (Fab) in the management of digoxin poisoning.
por: Brown, J. H., et al.
Publicado: (1986)

Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?
por: Saad, Antonio F., et al.
Publicado: (2016)

Chronic Digoxin Toxicity: An Evaluation of Digoxin-Specific Antibodies and Other Management Options
por: Clifford, Liam M, et al.
Publicado: (2023)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
por: Colella, Antonella, et al.
Publicado: (2022)

Neglected facts in digoxin intoxication
por: Serin, Sibel Ocak
Publicado: (2017)

‘Digoxin conundrum – Time for validation?’
por: Yadava, O.P.
Publicado: (2021)

Pharmacokinetic Considerations for Digoxin in Older People
por: Currie, Geoffrey M, et al.
Publicado: (2011)

Appropriateness of digoxin measurement in hospitalized patients
por: Oncu, Seyma, et al.
Publicado: (2017)

Immunosensor for Rapid and Sensitive Detection of Digoxin
por: Zhao, Shuyang, et al.
Publicado: (2023)

Speckle tracking echocardiography for management of patients with PVCs and normal ejection fraction
por: Roukoz, Henri
Publicado: (2021)

Pharmacokinetic Drug‐Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
por: Trivedi, Ashit, et al.
Publicado: (2021)

Racial disparities in cardiac transplantation: Chronological perspective and outcomes
por: Trivedi, Jaimin R., et al.
Publicado: (2022)

Efficiency of individual dosage of digoxin with calculated concentration
por: Zhao, Li, et al.
Publicado: (2014)

Digoxin intoxication: An old enemy in modern era
por: Kirilmaz, Bahadir, et al.
Publicado: (2012)

A DNA-Based Assay for Digoxin Detection
por: Kjelstrup, Michael V., et al.
Publicado: (2018)

Colored floaters as a manifestation of digoxin toxicity
por: Shi, Lynn, et al.
Publicado: (2018)

Digoxin-induced retinal degeneration depends on rhodopsin
por: Landfried, Britta, et al.
Publicado: (2017)

Digoxin in Atrial Fibrillation: An Old Topic Revisited
por: Ferrari, Filipe, et al.
Publicado: (2020)

Digoxin Induces Human Astrocyte Reaction In Vitro
por: Pamies, David, et al.
Publicado: (2022)

Inadvertent Intrathecal Administration of Digoxin, with Review of the Literature
por: Tabaac, Burton J., et al.
Publicado: (2023)

Safety of digoxin in nonagenarian patients with atrial fibrillation: lessons from the Spanish Multicenter Registry
por: Domínguez-Erquicia, Pablo, et al.
Publicado: (2021)

The effect of high dose digoxin on cytokines in healthy dogs.
por: Dülger, Haluk, et al.
Publicado: (2002)

The effect of digoxin on the binding of adriamycin to cat heart muscle.
por: Somberg, J., et al.
Publicado: (1977)

Severe suicidal digoxin and propranolol toxicity with insulin overdose
por: Garg, Ashish, et al.
Publicado: (2014)

Dronedarone-digoxin interaction in PALLAS: A foxglove connection?
por: ElMaghawry, Mohamed, et al.
Publicado: (2015)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Effect of green tea catechins on the pharmacokinetics of digoxin in humans
por: Kim, Tae-Eun, et al.
Publicado: (2018)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
por: Frost, Charles, et al.
Publicado: (2017)

Semimechanistic Modeling to Guide Venetoclax Coadministration with Ritonavir and Digoxin
por: Alhadab, Ali A., et al.
Publicado: (2020)

Detecting Digoxin Toxicity by Artificial Intelligence-Assisted Electrocardiography
por: Chang, Da-Wei, et al.
Publicado: (2021)

The effect of digoxin on renal function in patients with heart failure
por: Shah, Parin, et al.
Publicado: (2021)

Benefits of prescribing low-dose digoxin in atrial fibrillation
por: Rosca, Ciprian Ilie, et al.
Publicado: (2021)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a9dkd9hcbub8je29diuub4hq24